Preparation of antibiotics by fermentation

ABSTRACT

A fermentation process for preparing 7-methoxy substituted cephalosporins. The products are useful as antibiotics and exhibit activity against gram-negative and gram-positive bacteria.

United States Patent 1 Stapley et al.

[ 51 Oct. 21, 1975 PREPARATION OF ANTIBIOTICS BY FERMENTATION [44] Published under the Trial Voluntary Protest Program on January 28, 1975 as document no. B 331,417.

Related US. Application Data [63] Continuation-impart of Ser. Nos. 19,496, March 13, 1970, abandoned, and Ser. No. 51,319, June 30, 1970, abandoned, and Ser. No. 203,896, Dec. 1, 1971.

[52] US. Cl. 195/80 R; 260/240 J; 260/243 C [51] Int. Cl. C12D 9/00 [58] Field of Search 195/80 [56] References Cited UNITED STATES PATENTS 3,801,464 4/1974 Gorman et al 195/80 Primary Examiner-Samih N. Zaharna Assistant ExaminerRobert .l. Warden Attorney, Agent, or Firm-Julian S. Levitt; J. Jerome Behan [57] ABSTRACT A fermentation process for preparing 7-methoxy substituted cephalosporins. The products are useful as antibiotics and exhibit activity against gramnegative and gram-positive bacteria.

6 Claims, N0 Drawings PREPARATION OF ANTIBIOTICS BY F ERMENTATION graded to a form which is ineffective against most 15 pathogens. Efforts to overcome this difficulty via the preparation of various derivatives have met with only limited success.

One approach to this problem has been the devlopment of new antibiotics which contain the cephem nucleus characteristic of cephalosporin C. Cephalospo- HOOC-CH- (CH 3 -C-NH rin C is active against both gram-negative and grampositive bacteria and it possesses an inherent resistance to penicillinase; however, cephalosporin C is only moderately active and there exist enzymes other than penicillinase which are effective in destroying the activity of cephalosporin C and its derivatives. These enzymes are designated as cephalosporinases.

It is an object of this invention to describe a fermentation process for preparing an antibiotic mixture and individual compounds containing the cephem nucleus. These products exhibit individual resistance not only to penicillinase but to the cephalosporinases as well. Certain of the products exhibit an approximately balanced gram-negative and gram-positive effect, including activity in vivo against the following gram-negative organisms: Proteus vulgaris, Proteus mirabilis, Salmonella schottmuelleri, Salmonella gallinarum, Salmonella pullorum, Escherichia coli, and Klebsiella pneumoniae and in vivo activity against the following gram-positive organisms: Staphylococcus aureus, Streptococcus pyogenes and Diplococcus pneumoniae. Other products exhibit an enhanced activity against gram-negative microorganisms.

The products of this invention bear a structural relationship to the cephalosporin series of compounds; however, unlike cephalosporin C which contains only a D-S-amino-S-carboxyvaleramido moiety at position seven, the instant products also contain a 7-methoxy substituent; and, whereas cephalosporin C is substituted by acetoxymethyl at position three of the ring, the products of this invention contain a 3- carbamoyloxymethyl, 3-a-methoxy-p-sulfooxycinnamoyloxyrnethyl or a 3-a-methoxy-p-hydroxycinnamoyloxyrnethyl moiety:

p 2 O OCH ll 3 HOOC ICH- (CH "C -NH m 0 CH -R I coon wherein R is carbamoyloxy, a-methoxy-phydroxycinnamoyloxy or a-methoxy-psulfooxycinnamoyloxy.

Antibiotic 810A: Essentially, the products of Formula 1, supra, comprise two groups of fermentation products. One of these is a mixture of compounds from which two distinct products have been isolated and identified. These two products are characterized by the presence of an a-methoxy-p-sulfooxycinnamoyloxy or an a-methoxy-p-hydroxycinnamoyloxy moiety at position 3 of the cephem nucleus:

QCH

cooa con wherein R is hydroxy or sulfooxy, i.e., OSO H. These products are co-produced by cultivating under controlled conditions a new strain of actinomycete designated as MA-2837 in the culture collection of Merck & Co., Inc., Rahway, NJ. A sample of this culture has also been placed on permanent deposit with the culture collection of the Northern Utilization Research and Development Branch of the US. Department of Agriculture at Peoria, 111., and has been assigned the culture number NRRL 3851. Twenty-five other cultures have also been identified as producers of this antibiotic mixture (Ia) and these, together with culture MA-2837, are described infra in the section entitled THE MI- CROORGANISMS. Hereinafter the antibiotic mixture (Ia) comprising these two products will be referred to as Antibiotic 810A or, simply, 810A.

Antibiotic 842A: A second fennentation product comprises 7B-(D-5-amino-5-carboxyvaleramido)-3- (carbamoyloxymethyl)-7-methoxy-3-cephem-4- carboxylic acid (lb, infra):

This product (Ib) is also produced by a new strain of actinomycete and a sample of this microorganism, designated as MA-2908, has been placed in the culture collection of Merck & Co., Inc., Rahway, NJ. A sample of this culture has also been placed on permanent deposit with the culture collection of the Northern Utilization Research and Development Branch of the US. Department of Agriculture at Peoria, 111., where it has been assigned the culture number NRRL 3802. Hereinafter, in this specification, the product Ib, i.e., 7B-(D-5- amino-5-carboxyvaleramido)-3- (carbamoyloxymethyl)-7-methoxy-3-cephem-4- carboxylic acid, will be referred to as Antibiotic 842A or, simply, 842A.

ACTIVITY One major difficulty in antimicrobial therapy is the susceptibility of most antibiotics to enzymatic degradation. Penicillin G, for example, is effective against a wide variety of gram-positive and gram-negative microorganisms but in the presence of penicillinase it is degraded to a form which is ineffective against most pathogens.

One approach to this problem has been the development of new antibiotics which contain the cephem nucleus characteristic of cephalosporin C. Cephalosporin C possesses an inherent resistance to penicillinase and NH A2 aocn-cn ca -cn is active against both gram-negative and gram-positive bacteria; however, it is only moderately active and there exist enzymes other than penicillinase which are effective in destroying its activity. These enzymes are designated as cephalosporinases. The products (I) of this invention demonstrate resistance not only to penicillinase but to the cephalosporinases as well. They exhibit activity against both gram-negative and grampositive bacteria but the order of activity and the range of organisms against which they are effective is not identical.

Antibiotic 842A is characterized by an enhanced activity against gram-negative microorganisms. Unlike cepahlosporin C which has a relatively low antibacterial activity, this product exhibits a significant in vivo gram-negative effect with a potency which, in general, is greater than cephalothin. This activity includes effectiveness in vivo on Proteus morganii and an effectiveness against the following gram-negative bacteria: Escherichia coli, Proteus vulgaris, Proteus mirabilis, Proteus morganii, Salmonella schottmuelleri, Klebsiella pneumoniae AD, Klebsiella pneumoniae B, and Paracolobactrum arizonae.

Antibiotic 842A constitutes a preferred embodiment of this invention. In addition to a generally increased gram-negative effect and an increased potency when compared to cephalothin and a greater resistance to cephalosporinases, 842A is characterized by a low order of toxicity and appears rapidly in the blood. Within four hours after administration approximately 80% is eliminated in the urine. In addition it is more resistant to enzymatic degradation than cephalosporin C and resistance to it develops slowly and it is bactericidal. Given orally it protects against infections due to Paracolobactrum arizonae 3270, Proteus vulgaris 1810, and Salmonella schottmuelleri 3010; and when administered subcutaneously, it is from two to ten times more effective than cephalothin against the same infections.

Antibiotic 810A is a broad spectrum agent which exhibits an approximately balanced gram-negative and gram-positive effect. This includes activity in vivo against the following gram-negative organisms: Proteus vulgaris, Proteus mirabilis, Salmonella pullorum, Escherichia coli, and Klebsiella pneumoniae and in vivo activity against the following gram-positive organisms: Staphylococcus aureus, Streptococcus pyogenes and Diplococcus pneumoniae.

Of the several products comprising Antibiotic 810A the 7B-(D-5-amino-S-carboxyvaleramido)-3-(amethoxy-p-sulfooxycinnamoyloxymethyl)-7-methoxy- 3-cephem-4-carboxylic acid species, corresponding to Formula Ia, supra, wherein R is sulfooxy, and the salts thereof such as the sodium salt, constitutes a preferred embodiment of this invention. This product has the following planar formula:

COOH

This compound has a greater resistance to cephalosporinases than cephalothin and is characterized by a low order of toxicity in mice. In addition it is more resistant to enzymatic degradation than cephalosporin C and it is bactericidal. Given orally it protects against infections due to Proteus vulgaris and, when administered intraperitoneally, it is effective against a variety of gram-negative and gram-positive infections.

THE MICROORGANISMS 810A Cultures: The microorganism which produces Antibiotic 810A was originally isolated as a single colony from soil. This colony was passed onto a streak plate of the following composition:

Medium A:

Yeast Extract 10.0 g. Dextrose 10.0 g. Agar 20.0 g. 'Distilled Water 1000.0 ml.

After several days of growth the microorganism produced the Antibiotic 810A. This antibiotic was then reproduced in shake flasks and differentiated from known antibiotics on the basis of various biological and chemical studies. Comparison of this data with that obtained via other known antibiotics established 810A as a new entity.

810A Taxonomy and Morphology: The microorganism (Culture MA-2837) which produces Antibiotic 810A has been identified as Streptamyces griseus. The taxonomy employed in this determination is described in Bergeys Manual of Determinative Bacteriology, Seventh Edition; and in The Actinomycetes", Vol. 2, by S. A. Waksman (1961). Using that procedure the culture was found to be a strain of Streptomyces griseus which closely resembles Streptomyces griseinus in description, melanin production and carbon utilization as described in Waksman and in the International Journal of Systematic Bacteriology, Vol. 18: page 236 (1968). However, in both Waksman and in the International Journal of Systematic Bacteriology, Streptomyces griseinus is narrowly defined as the griseinproducing strain of Streptomyces griseus" or as producing grisein or grisein-like substances". Streptomyces griseus (MA-2837) is a strain that differs from the classic description in Bergey and in Waksman inasmuch as it possesses an aerial myeelium which is predominately tannish yellow and greenish yellow on some media and with a slightly different carbon utilization pattern. Waksman, on pages 111 and 133 of The Actinomycetes describes that Streptomyces griseus series as one which encompasses many related species and strains, as characterized by colorless to olive-buff substrate growth, aerial myeelium that is yellowish with a greenish tint, or greenish-grey or sear or grass-green to grey, melanin negative, sphorophores straight or flexuous and produced in tufts, spores oval. The following Tables compare the characterisitcs of the culture which produces Antibiotic 810A and the Streptomyces griseus and Streptomyces griseinus cultures.

The characterization of the parent isolate MA-2837 as compared with Streptomyces griseus described in Bergey and Waksman and, also, the characterization of MA-2837 as compared with Streptomyces griseinus as described in Waksman are set forth in Tables I and la, infra.

TABLE I COMPARISON OF CULTURAL CHARACTERISTICS OF MA-2837 CULTURE Streptomyce:

S Ireptom yces S Ireplom yces griseux (Bergey) griseus (Waksman) griseinus waksman Aerial myeelium:

Abundant, powdery.

water green. Sporo phores produced in tufts. Spores spherical to ellipsoidal, 0.8 by 0.8 to 1.7 microns. Vegetative growth: Colonies smooth or folded, colorless, later turning olivebuff.

Sporophores straight produced in tufts. Spores spherical to oval, 0.8 by 0.8 to 1.7;1; surface smooth.

Straight sporophores produced in clusters or tufts, without spirals.

Spores rod-shaped, 1.0 to 1.8 by 0.8 to 1.0p.

asparagine agar 970x Bergey's "Manual of Determinative Bacteriology", Seventh Edition (1957). Z Waksman. S. A., "The Actinomycetes", Vol. 2 (1961).

Medium MA-2837 TABLE Ia COMPARISON OF CULTURAL CHARACTERISTICS OF MA-2837 CULTURE S. griseus S. griseus S. griseinux (Bergey) (Waksman) (Waksman) Vegetative Growth: Reverse brown, flat, spreading Aerial Mycelium: Center-tan to grayish-yellow; edgetannish yellow Soluble Pigment: Tan

Vegetative Growth: Reversetan, flat, spreading Aerial Mycelium: Powdery,

tannish-yellow Tomato paste oatmeal Agar Glycerol-asparagine Agar Czapek-Dox Agar (Sucrose nitrate agar) Egg Albumin agar Substrate growth wrinkled. reverse cream-colored to brownish. Aerial myeelium white to cream-colored with light greenish tinge. No soluble pigment Growth thin, spreading, colorless. becoming olive-buff. Aerial myeelium thick. powdery. water green, pigment insoluble.

TAB LE Ia Continued Medium COMPARISON OF CULTURAL CHARACTERISTICS OF MA-2837 CULTURE MA-2837 S. griseus Bergey S. griseus (Waksman S. griseinus (Waksman) Nutrient Agar Agar Synthetic Agar Gelatin Stab Nutrient Gelatin Agar Litmus Milk Skim Milk Skim Milk Agar Glucose Agar Glucose Broth Starch Agar Nutrient Starch Agar Potato Plug Calcium Malate Agar Vegetative Growth: Cream Aerial Mycelium: Pale,

tannish yellow Soluble Pigment: None Liquefaction of gelatingood.

Partial ring Vegetative Growth: Brownish Aerial Mycelium: Slight.

whitish Peptonization, becoming alkaline Panial ring Vegetative Growth: Brownish Aerial Mycelium: None Soluble Pigment: Light brown Peptonization. becoming alkaline Vegetative Growth: Cream.

flat. spreading Aerial Mycelium: Sparse,

yellowish white to cream Soluble Pigment: Very light brown Hydrolysis of casein Abundant, yellow ish pellicle with greenish tinge, much folded Thin, spreading transparent growth Starch is hydrolyzed.

Vegetative Growth: Cream Aerial Mycelium: Pale tannish yellow Soluble Pigment: None Hydrolysis good Vegetative Growth: Light Yellowish, wrinkled brown growth covered with Aerial Mycelium: Moderate, white, powdery tan aerial mycelium. Slight browning of potato.

Vegetative Growth: Flat,

spreading, translucent and colorless at edges, opaque and creamcolored in center.

Aerial Mycelium: Moderate,

cream to yellow, edges tannish yellow Soluble Pigment: None Growth abundant. almost transparent. cream-colored. Aerial mycelium powdery. white to light grey. No soluble pigment.

Greenish yellow or cream-colored surface growth with brownish tinge. Rapid liquefaction.

Cream-colored ring; coagulation with rapid peptoniaztion, becoming alkaline.

Growth elevated in center, radiate, cream-colored to orange. erose margin Growth thin. spreading, transparent, hydrolysis strong Growth wrinkled. yellowish to brownish, covered with white. powdery aerial mycelium.

Green or yellow soluble pigment produced on calcium malate and succinate media.

Growth cream-colored with brownish tinge. Aerial mycelium absent or scant, white.

Rapid liquefaction.

Growth cream-colored.

Coagulation with peptonization.

Colorless to creamcolored growth Aerial mycelium grayish-olive. Hydrolysis rapid Growth wrinkled, yellowish-white. Aerial mycelium grayish white with olive tinge.

No soluble pigments on calcium malate or succinate media.

TABLE la -Continued Medium MA-2837 S. griseus S. grisem' S. griseinus (Bergey) (Waksman) (Waksman) Nutrient Vegetative Growth: Flat Dark pigment often No pigment produced Tyrosine Agar spreading, cream-colored produced Aerial Mycelium: Yellowish tan with greenish cast, edges tannish yellow Soluble Pigment: Very light brown Tyrosine crystals decomposed. Peptone-iron' Vegetative Growth: Creamyeast Extract colored Agar Aerial Mycelium: None Soluble Pigment: None Melanin negative Production of H 8 Negative Negative Negative Loefflers Blood Vegetative Growth: Tan Serum Slants Aerial Mycelium: Slight,

yellowish Soluble Pigment: Brownish Complete liquefaction. Temperature 28C good growth Optimum temperature Range (yeast 37C good growth 37C. extract-dextrose- 50C no growth salts agar slants) Microaerophilic Good growth covering Aerobic Growth (yeast exsurface and along tract-dextroseentire stab line. salts stab-4O mm depth) Reduction of Negative Positive Positive Positive nitrates to nitrites These observations were made after 3 weeks incubation at 28C. except where otherwise noted. The pH of the media used in these studies was approximately neutral, that is, 6.8 to 7.2. The physiological tests were run at the end of 7 and 22 days. The colors used in the description are in accordance with the definitions of the Color Harmony Manual, Fourth Edition, 1958; Container Corporation of America.

810A Carbohydrate Utilization TABLE I1 MA-2837 MA-2837 Carbohydrate Culture Carbohydrate Culture Glucose Lactose Arabinose lnositol Xylose Sucrose Maltese Rhamnose Mannose Raffinose Fructose Cellulose Mannitol The characteristics described in Table I, la and II were used to reduce the Streptomyces griseus culture (MA-2837) to a species classification via the keys described in Bergeys Manual of Determinative Bacteriology, Seventh Edition, pages 694-829 (1957) and in The Actinomycetes, Vol. 2: pages 61-292 (1961). A comparison of the culture (MA-2837) with known species shows that it is similar to Streptomyces griseus. There are morphological differences as, for example, in the color of the aerial mycelium which, in Streptomyces griseus, is predominantly tannish yellow and greenish yellow but, in view of the significant number of similarities and the only minor differences there is no justification for a new species name. As a result, the microorganism (MA-2837) which produces Antibiotic 810A has been identified as a strain of Streptomyces griseus. In addition to the foregoing culture (MA-2837), 25 additional cultures have been identified as producers of the Antibiotic 810A. These include: three cultures of Streptomyces griseus, eleven cultures of Streptomyces viridochromogenes, five cultures of Streptomyces fimbriatus, three cultures of Streptomyces halstedii, one culture of Streptomyces rochei, one culture of Streptomyces cinnamonensis and one culture of Streptomyces chartreusis. These strains of Streptomyces are identified as cultures MA-4l60, MA-4l74, MA-4l7l, MA- 4177, MA-4l78, MA-4180, MA-4l64, MA-4l65, MA- 4166, MA-4l67, MA-2892, MA-3265, MA-4l62, MA- 4163, MA-4l59, MA-4l69, MA-4l70, MA-4179, MA- 4161, MA-4168, MA-4l75, MA-4l8l, MA-2938, MA- 4176 and MA-4l73 in the culture collection of Merck & Co., Inc., Rahway, NJ. These cultures have been placed on permanent deposit with the culture collection of the Northern Utilization Research and Development Branch of the US. Department of Agriculture at Peoria, Ill. The assigned NRRL culture numbers are as follows:

Srreptomyces griseur:

Streptomyces viridochromugenes:

MA-4 l 77 MA-4l 78 MA-4l 80 MA-4l 64 MA-4l65 MA-4l 66 MA-4l 67 MA-2892 MA-326S MA-4l 62 MA-4I63 Srreptomyces fimbriatus:

MA 4l 59 MA-4l 69 MA-4I70 MA-4l79 MA-4 l 61 Streplomyces halsledii:

NRRL 3970 MA-4l68 NRRL 3959 NRRL 3971 MA-4l75 NRRL 3960 NRRL 3972 MA-4l8l NRRL 3961 NRRL 3966 Slreplomyces rochei: NRRL 3967 MA-2938 NRRL 3973 NRRL 3968 5 Streptomyces cinnamonensis: NRRL 3969 MA-4l76 NRRL 3974 NRRL 3962 Slreptomyces charrreusis: NRRL 3963 MA-4l73 NRRL 3975 NRRL 3964 NRRL 3965 The characterization of the aforementioned isolates 10 for comparison with Streptomyces griseus, S treptomyces NRRL 3954 viridochromogenes, Streptomycesfimbriatus, Streptomyfiggt 332$ ces halstedii, Streptomyces rochei, Streptomyces cin- NRRL 3953 namonensis and Streptomyces chartreusis are set forth NRRL 3955 below in Tables IIa-IIe.

TABLE Ila CULTURAL CHARACTERISTICS OF STRAINS OF STREPTOMYCES GRISEUS PRODUCING ANTIBIOTIC 8lOA Medium MA-4l60 MA-4l74 MA-4l7l Morphology Sporophores form tufts with spore chains straight to slightly Tomato Paste Oatmeal Agar Glycerolasparagine Agar Czapek-Dox Agar Yeast Extract Dextrose Salts Agar Soluble Pigment on Peptone-Iron- Yeast Extract Agar flexuous. Spores are spherical to oval 0.9;; dia. to 0.90;; X 1.2g, in chains of approximately 10-15 sporesl Vegetative Growth: Good, flat, spreading. tan

Aerial Mycelium: Aerial Mycelium: Aerial Mycelium:

Powdery; tan with Powdery; tan with Powdery; tan with greenish cast strong green over strong green overtone tone Soluble Pigment: Light brown Vegetative Growth: Good, flat. tan

Aerial Mycelium: Powdery, tan with greenish cast and vectors of gray-green Soluble Pigment: Light brown Vegetative Growth: Flat. spreading transparent Aerial Mycelium: Aerial Mycelium: Aerial Mycelium:

Moderate; tan Moderate; tan Moderate; grayish Soluble Pigment: Soluble Pigment: Soluble Pigment:

Light brown Light brown None Vegetative Growth: Flat. spreading, tan Aerial Mycelium: Good, powdery, beige Soluble Pigment: Light brown None None None TABLE IIb CULTURAL CHARACTERISTICS OF STRAINS OF STREPTOMYCES VIRIDOCHROMOGENES PRODUCING ANTIBIOTIC 810A Medium Morphology Sporophores are short, compact spirals occurring as side brancheson aerial hyphae.

Vegetative Growth:

Tomato Paste- Oatmeal Agar Glycerolaspara gine Agar Vegetative G rowth: Reverse brown Aerial Mycelium: Velvety; dark gray /2 white Soluble Pigment: Light brown Vegetative Growth:

Reverse dark brown Aerial Mycelium:

Dark gray and cream Soluble Pigment: Light brown Vegetative Growth:

Reverse tan Aerial Mycelium: Velvety; light gray white Soluble Pigment:

None

Vegetative G rowth:

Reverse dark brown Aerial Mycelium:

Light gray Soluble Pigment:

N one Vegetative Growth:

Reverse dark brown Aerial Mycelium: Velvety; light gray /z white Soluble Pigment:

None

Vegetative Growth:

Reverse dark brown Aerial Mycelium:

Cream /5 Light gray Soluble Pigment: Light brown Reverse brown Aerial Mycelium:

Velvety; medium gray 6 white Soluble Pigment: Light brown Vegetative Growth: Reverse brown Aerial Mycelium:

Cream gray Soluble Pigment: Light brown TABLE [lb-Continued CU LTURAL CHARACTERISTICS OF STRAINS OF m STREPTOMYCES VIRIDOCHROMOGENES PRODUCING ANTIBIOTICBIOA Medium MA-2892 MA-3265 MA-4l62 MA-4l 63 Czapek'Dox Vegetative Growth: Vegetative Growth: Vegetative Growth: Vegetative Growth: Agar Dark brown Dark brown Dark brown tan Aerial Mycelium: Aerial Mycelium: Aerial Mycelium: Aerial Mycelium:

Very scant Light gray & Very scant Very scant white Soluble Pigment: Soluble Pigment: Soluble Pigment: Soluble Pigment: Dark brown Light brown Light brown Light brown Yeast Extract Vegetative Growth:

Vegetative Growth:

Vegetative Growth:

Vegetative Growth:

Dextrose Agar Dark Brown Reverse brown Dark brown Dark brown Aerial Mycelium: Aerial Mycelium: Aerial Mycelium: Aerial Mycelium:

Very scant Light gray Very scant Very scant Soluble Pigment: Soluble Pigment: Soluble Pigment: Soluble Pigment: Light brown None Light brown Light brown Soluble Pigment on Peptone Dark brown Iron-Yeast Extract Agar Medium MA-4l64 MA-4l65 MA-4l66 MA-4l67 Morphology Sporophores are short, compact spirals occurring as side branches on aerial hyphae.

Spores are spherical to oval 0.9 to 1.2 diameter and 0.9 [.2 X l.2 l.7 in chains of approximately l0-15 spores. Tomato Paste Vegetative Growth: Reverse dark brown Oatmeal Agar Glycerol-asparagine Agar Czapek-Dox Agar Yeast Extract Dextrose Agar Soluble Pigment on Peptone- Iron-Yeast Extract Agar Medium Morphology Tomato Paste Oatmeal Agar Glycerol-asparagine Agar Czapek-Dox Agar Yeast Extract Dextrose Agar Soluble Pigment on Peptone- Iron-Yeast Extract Agar Aerial Mycelium: Velvety; bluegray & cream Vegetative Growth:

Reverse dark brown Aerial Mycelium: Dark gray &

cream Vegetative Growth:

Brown Aerial Mycelium:

Very scant Soluble Pigment:

Brown Sporophores are short. compact spirals occurring as side branches Aerial Mycelium:

Velvety; medium gray & cream Aerial Mycelium:

Velvety; medium gray & cream Soluble Pigment: Light brown Vegetative Growth:

Reverse dark brown Aerial Mycelium:

Medium gray &

cream Vegetative Growth:

Dark gray Aerial Mycelium: Scant-greyish Soluble Pigment: Light brown Vegetative Growth: Reverse brown Aerial Mycelium: Light gray & cream Soluble Pigment: Light brown Vegetative Growth:

Brown Aerial Mycelium:

Very scant Soluble Pigment:

Brown Vegetative Growth: Dark brown Aerial Mycelium: Soluble Pigment: Light brown Dark brown on aerial hyphae. Spores are spherical to oval 0.9 to L2 diameter and 0.9 l.2 X 1.2 1.7g. in chains of approximately Vegetative Growth:

Reverse tan Aerial Mycelium:

Velvety; dark gray & white Vegetative Growth:

Reverse brown Aerial Mycelium: Velvety; dark Vegetative Growth: Reverse brown Aerial Mycelium:

Velvety; dark gray & cream Aerial Mycelium: Velvety; dark gray & cream Vegetative Growth:

Reverse tan Aerial Mycelium: Light gray &

cream Vegetative Growth:

Tan Aerial Mycelium:

Very scant Soluble Pigment: Light brown Very scant y Soluble Pigment: Light brown Vegetative Growth: Vegetative Growth:

Reverse dark brown Reverse dark brown Aerial Mycelium: Aerial Mycelium:

Dark gray Mixture of light &

dark gray Vegetative Growth: Reverse brown Aerial Mycelium:

Dark gray Vegetative Growth: Vegetative Growth: Vegetative Growth:

Dark brown brown Brown Aerial Mycelium: Aerial Mycelium: Aerial Mycelium: Scam-grayish Very scant Very scant Soluble Pigment: Light brown Dark brown TABLE Ilc CULTURAL CHARACTERISTICS OF STRAINS OF STREPTOMYCES FIMBRIATUS PRODUCING ANTIBIOTIC 8l0A Medium MA-4l59 MA-4l69 MA-4I7O MA-4l79 MA-4l6l Morphology Sporophores are short, compact spirals and some loops, occurring as side Sporophores are branches on aerial hyphae. Spores are spherical to oval 0.9p. diameter short hooks & and 0.9 X 1.2;; chains of approximately lO-l5 spores. loops. occurring as side branches on aerial mycelium: Spores are in chains of less than l0 spores spherical to oval 0.9;; diameter & 0.9 X I.2p.

Tomato Vegetative Growth: Vegetative Growth: Vegetative Growth: Vegetative Growth: Vegetative Growth:

Paste Reverse tan Reverse tan Reverse tan Reverse tan Tan Agar Aerial Mycelium: Aerial Mycelium: Aerial Mycelium: Aerial Mycelium: Aerial Mycelium:

Moderate; light Moderate; light Moderate; light Sparse. grayish Scant; grayish gray gray gray & cream Soluble Pigment: Light brown Glycerol- Vegetative Growth: Vegetative Growth: Vegetative Growth: Vegetative Growth: Vegetative Growth:

asparagine Dark brownish- Dark brownish- Dark brownish- Dark brownish- Reverse tan with Agar gray gray gray gray reddish tan vector Czapek-Dox Vegetative Growth: Vegetative Growth: Vegetative Growth: Vegetative Growth: Vegetative Growth:

Agar Dark brownish- Dark brownish- Dark brownish Dark brownish- Tan y y y y Aerial Mycelium: Aerial Mycelium: Aerial Mycelium: Aerial Mycelium: Aerial Mycelium:

Very scant Moderate; gray Moderate; gray Very scant Very scant Soluble Pigment: Soluble Pigment: Soluble Pigment: Soluble Pigment: Soluble Pigment: Brown Brown Brown Brown Light brown Yeast Vegetative Growth: Vegetative Growth: Vegetative Growth: Vegetative Growth: Vegetative Growth:

Extract Dark brownish- Dark brownish- Dark brownish- Dark brownish- Brown Dextrose gray gray gray gray Salts Agar Aerial Mycelium: Very scant Soluble Pigment: Brown Soluble Pigment on Peptone- Dark brown Iron-Yeast Extract Agar TABLE Ild CULTURAL CHARACTERISTICS OF STRAINS OF STREPTOMYCES HALSTEDII PRODUCING ANTIBIOTIC 810A Medium MA-4I68 MA-4I75 MA-4l8l Morphology Sporophores are long, loose spirals occurring as side branches on Tomato Paste- Oatmeal Agar Glycerol-asparagine Agar Czapek-Dox Agar Yeast Extract Dextrose Salts Agar aerial hyphae. Spores are spherical to oval 0.9;). diameter and 0.9 X l.2p. in chains of more than I0 spores. Vegetative Growth: Vegetative Growth:

Reverse brown Reverse tan Aerial Mycelium: Aerial Mycelium:

Powdery; dark Dark grey & white; grey powdery Soluble Pigment: None Vegetative Growth:

Reverse greyish Vegetative Growth: Reverse brown Aerial Mycelium:

Dark grey & white Vegetative Growth:

Vegetative Growth:

Reverse greyish Reverse brown to dark brown Aerial Mycelium:

Powdery; dark grey and white Aerial Mycelium:

Dark' grey: powdery Vegetative Growth:

Vegetative Growth:

Cream Cream Aerial Mycelium:

Aerial Mycelium:

Very scant Greyish cream Vegetative Growth:

Vegetative Growth:

Brown Tan Aerial Mycelium:

Greyish; scant Soluble Pigment: None Aerial Mycelium:

Scant; greyish Aerial Mycelium:

Scant; greyish Peptone-Iron- None Yeast Extract Agar TABLE He CULTURAL CHARACTERISTICS OF STREPTOMYCES SPECIES PRODUCING ANTIBIOTlC 810A Medium Morphology Tomato Paste Oatmeal Agar Glycerol-asparagine Agar Czapek-Dox Agar Yeast Extract Dextrose Salts Agar Soluble Pigment Streptomyces rochei Sporophores form compact spirals occurring as side chains of approximately -15 spores spherical to oval, 0.9a diameter &

Vegetative Growth: Reverse reddish-brown Aerial Mycelium: Medium Soluble Pigment: None Vegetative Growth:

Reverse reddish-brown Aerial Mycelium: Medium y Soluble Pigment: None Vegetative Growth: Reddish brown Aerial Mycelium:

Very scant Soluble Pigment: None Vegetative Growth: Tan

Aerial Mycelium:

Grayish Soluble Pigment: Light brown None Streptomyces cinnamonenxi: Sporophores are hooks, loops, & a few loose spirals. occurring as side branches on aerial hyphae. Spores are in chains of more than 10 spores spherical to oval, 0.9;. diameter & 0.9 X 1.2g. Vegetative Growth: Tan

Aerial Mycelium: Beige with pink tint; velvety Soluble Pigment: Brown Vegetative Growth:

Reverse dark reddishbrown Aerial Mycelium: Beige with pink tint Soluble Pigment: Brown Vegetative Growth:

Reverse dark brown Aerial Mycelium:

Moderate; beige with pink tint Soluble Pigment: Brown Vegetative Growth: Brown Aerial Mycelium: Sparse creamish-white Soluble Pigment: Light brown Dark Brown Aerial Mycelium: Very scant Soluble Pigmentz Light brown Vegetative Growth:

Orange-brown Aerial Mycelium: Very scant Soluble Pigment: Light brown Vegetative Growth: Brown Aerial Mycelium:

Very scant Soluble Pigment: Brown Dark Brown on Peptone-lron- Yeast Extract Agar The foregoing description of the microoganisms producing Antibiotic 810A is simply illustrative of the type of strains which can be used and it should be understood that this invention is not limited to an organism meeting these particular descriptions. This invention includes the use of other microorganisms including strains of actinomycetes isolated from nature or obtained by mutation as, for example, those obtained by natural selection or those produced by mutating agents as, for example, X-ray irradiation, ultraviolet irradiation, nitrogen mustards and the like which, under suitable conditions will yield an identical antibiotic.

842A Culture: The microorganism which produces Antibiotic 842A is a previously unknown strain of actinomycete. The original isolate was obtained as a single colony from soil on an agar slant and grown in a medium having the following composition:

Medium B:

Yeast Extract 10.0 Glucose 10.0 g. *Phosphate Buffer 2.0 ml. MgSO 7H O 0.05 g. Distilled Water 1000.0 ml.

"Phosphate Buffer:

KH PO 91.0 g. NA HPO 95.0 g. Distilled Water 1000.0 ml.

After several days of growth it was found that no sporulation could be detected. The microorganism produced an antibiotic which was differentiated from known antibiotics on the basis of its profile in various biological and chemical studies. Comparison of this data with that obtained via other known antibiotics established 842A as a new entity.

842A Taxonomy: The microorganism (Culture MA- 2908) which produces 842A has been identified as a new species of actinomycetes. The taxonomy employed in this determination is described in Bergeys Manual of Determinative Bacteriology, Seventh edition; and in The Actinomycetes, Vol. 2, Classification, Identification and Description of Genera and Species", S. A. Waksman (1961). Using that procedure the culture was found to belong to the genus Streptomyces and it possesses many of the attributes of the known species Streptomyces fradz'ae. Biochemically it is an essentially perfect match with the latter. Morphologically, however, there are important differences. For example, the color of the aerial mycelium of S. fradiae is a seashell pink whereas the culture MA-2908 is usually cream colored. Also, the vegetative growth in the MA-2908 culture shows pigment differences of the various media employed, and, as stated below, no sporulation was detected on standard taxonomic media. On the basis of these differences, the culture was assigned a new species name: Streptomyces lactamdurans. Table III, infra, describes the biochemical attributes of the Streptomyces lactamdurans species and those of the known Streptomyces fradiae. All of the readings in Table III were taken after three weeks incubation at 28C. except where otherwise noted. The pH of the media used in these studies was approximately neutral, namely, 6.8 to 7.2. The physiological tests were run at the end of 7 and 22 days.

TABLE III 842A Biochemical Comparison Test S lreplom yces S Ireplum yce: fradiae peptonization peptonization 842A Morphology: cream Sporophores were not detected when the culture was grown on the media listed in the description of culture characteristics even though repeated observations were made up to 8 weeks. However, stained impression slides showed long filaments, many segmented into subunits of various sizes, generally rod shaped and approximately 0.9 by 1.7 microns in size. Tomato-Paste-Oatmeal Agar Vegetative growth reverse orange; flat, dry appearing, wrinkled Aerial Mycelium sparse, cream No soluble pigment Czapek-Dox Agar Vegetative flat, deep cream Aerial Mycelium powdery, creamish white No soluble pigment Glycerol-Asparagine Agar Vegetative growth flat, reverse golden yellow to orange Aerial Mycelium powdery, cream with pale peach tones Soluble pigment pale amber Egg Albumin Agar Vegetative growth flat, cream to yellow Aerial Mycelium powdery, cream No soluble pigment Calcium Malate Agar Vegetative growth flat; reverse yellow edged with orange Aerial Mycelium powdery, white to cream edged with peach No soluble pigment Nutrient Tyrosine Agar Vegetative growth flat, tan to orange Aerial Mycelium sparse, cream with white No soluble pigment Tyrosine crystals decomposed Molasses Yeast Hydrolysate Agar Vegetative growth flat; reverse orange Aerial Mycelium powdery, creamish white No soluble pigment Nutrient Agar Vegetative growth flat, golden yellow Aerial Mycelium powdery, cream No soluble pigment Litmus Milk Sparse growth ring tan vegetative growth no aerial mycelium Peptonization: alkaline reaction; pH 7.3 7.4 (Control pH 6.7) Skim Milk Sparse growth ring tan to orange Vegetative growth no aerial mycelium Light tan soluble pigment Peptonization alkaline reaction pH 7.2 (Control pH 6.6) Skim Milk Agar Vegetative growth flat, orange Aerial Mycelium moderate, cream to pale coral Light tan soluble pigment Hydrolysis of casein Gelatin Stab Sparse cream to orange colored flaky vegetative growth suspended throughout tube No soluble pigment Complete liquefaction Nutrient Gelatin Agar Vegetative growth flat, orange Aerial Mycelium sparse, powdery, cream No soluble pigment Liquefaction of gelatin Nutrient Starch Agar Vegetative growth flat, orange Aerial Mycelium sparse, powdery, pinkish cream No soluble pigment Moderate hydrolysis of starch Synthetic Starch Agar Vegetative growth flat; reverse cream edged with orange Aerial Mycelium powdery, white edged with peach No soluble pigment Moderate hydrolysis of starch Loefflers Blood Serum Agar Vegetative growth cream colored to orange Aerial Mycelium none No soluble pigment No liquefaction Peptone-lron-Yeast Extract Agar Vegetative growth cream Aerial-sparse-whitish No soluble pigment Microaerophilic Growth (Yeast extract-dextrose stab 40 mm. depth of stab.) Good surface growth and along upper one-fourth of stab line. Temperature Yeast extract-dextrose slants Good growth at 28C. Sparse growth at 37C. No growth at 50C. Yeast Extract Dextrose Agar Vegetative growth flat, golden yellow Aerial Mycelium powdery, cream to pale flesh pink No soluble pigment Potato plug Vegetative growth dry, flat, cream to orange Aerial Mycelium sparse, creamish No soluble pigment Reduction of Nitrates to Nitrites Negative All readings were taken after 3 weeks incubation at 28C. except where noted otherwise. Physiological tests were run at 7 and 21 days.

The morphological differences between Streptomyces Iactamdurans and Streptomyces fradiae are set forth in Table IV, infra. The observations were made on the media indicated in Table IV at growth intervals of one week, 3 weeks and 8 weeks. The aerial mycelium of S. laclamdurans is short and straight with little branching. It appears to be about the same size as the vegetative mycelium, i.e., 0.9 micrometer in width. It is light, powdery and scrapes off easily. The vegetative mycelium is gram-positive; it is not acid-fast. It clings to and in some media is imbedded in the agar. There is some fragmentation into rods in shake-flask growth but this is not extensive. Vegetative mycelium from shaker and stationary flasks (seed medium 4 to 6 days, 28C.) showed 10 some buds and short, thickened, almost club-shaped segments on mycelium but these were not numerous. All of the readings in Table IV were taken after 3 weeks incubation at 28C. except where otherwise noted. The

pH of the media used in these studies was approximately neutral, that is, 6.8 to 7.2. The physiological tests were run at the end of 7 and 21 days. The colors used in the description are in accordance with the definitions of the Color Harmony Manual, Fourth Edition, 1958; Container Corporation of America.

TABLE IV The characteristics described in Tables [11, IV and V were used to reduce the Streptomyces lactamdurans culture (MA-2908) to a species classification via the keys described in Bergey's Manual of Determinative 842A; Morphological Comparison of Slreptomyces laclamdurans and Streptomyces fradiae Medium Streptomyces lactamdurans Srreplomyces fradiae Czapek-Dox Agar Vegetative Growth:

Aerial Mycelium:

No Soluble Pigment Nutrient Agar Vegetative Growth:

yellow Aerial Mycelium:

No Soluble Pigment Flat, deep cream Powdery, creamish white Flat, cream to golden Powdery, cream Colorless Seashell pink Vegetative Growth: Aerial Mycelium:

Vegetative Growth: Orange-yellow Glycerol-Asparagine Vegetative Growth: Flat, reverse golden Vegetative Growth: Buffcolored Agar yellow to orange Aerial Mycelium: Powdery, cream with pale peach tones Soluble Pigment: Pale amber Yeast Extract Vegetative Growth: Flat, golden yellow Vegetative Growth: Buff-colored Dextrose Agar Aerial Mycelium: Powdery cream to pale flesh pink No Soluble Pigment Synthetic Starch Vegetative Growth: Flat, reverse cream Vegetative Growth: Colorless Agar edged with orange Aerial Mycelium: Powdery, white edged Aerial Mycelium: Seashell pink with peach No Soluble Pigment Moderate Hydrolysis of Starch Potato Plug Vegetative Growth: Dry, flat. cream to Vegetative Growth: Orange orange Aerial Mycelium: Sparse, creamish No Soluble Pigment Gelatin Stab Vegetative Growth: Sparse cream to orange Vegetative Growth: Cream to brown flakes suspended throughout the tube Aerial Mycelium: No Soluble Pigment Complete Liquefaction Litmus Milk Vegetative Growth: Tan; sparse growth ring Vegetative Growth: Cream colored Aerial Mycelium: None Peptonization, alkaline reaction; pH 7.3 7.4

(Control pH: 6.7)

842A Carbohydrate Utilization: The Streptomyces lactamdurans culture (MA-2908) was also tested for its ability to utilize or assimilate various carbohydrates by growing the microorganism in a basal synthetic medium (T.G. Pridham and D. Gottlieb; Journal of Bacte- (MA-2908). The explanation of the symbols in Table V are as follows: indicates good growth, indicates poor growth and indicates no growth on the particular carbohydrate.

Bacteriology, Seventh Edition, pages 694-829 (1957) and in The Actinomycetes, Vol. 2: pages 61-292 1961). A comparison of the detailed characteristics of the Streptomyces lactamdurans culture with know species showed that the culture is biochemically similar to Streptomyces fradiae. However, as indicated above, there are important morphological differences as, for example, in the color of the aerial mycelium of S. fradiae which is seashell pink as compared to the cream color of the culture. Also, the vegetative growth with S. fradiae shows pigment differences on the various media and no sporulation was detected with the culture MA- 2908, On the basis of these differences and the characteristics described in the foregoing Tables the microorganism producing antibiotic 842A (MA-2908) was assigned the new species name Streptomyces lactamdurans.

The foregoing description of the microorganism which produces antibiotic 842A is simply illustrative of the type of strains of -microorganisms which can be used and it should be understood that the present invention is not limited to organisms meeting these particular descriptions. This invention includes the use of other microorganisms, including strains of actinomycetes either isolated from nature or obtained by mutation as, for example, those obtained by natural selection or those produced by mutating agents, for example, X-ray irradiation, ultraviolet irradiation, nitrogen mustards and the like which, under suitable conditions, will afford the 842A product.

24 IN VITRO AND IN VIVO STUDIES pticldentification, Applied Microbiology, Vol. 6:

pages 392-398 (1958). The following Tables VI, VII, and VIII set forth the results of these antibacterial and cross-resistance tests and indicate the test organisms used and the conditions employed.

TABLE VI 810A ANTIBACTERIAL SPECTRUM; In Vitro Activity I Inhibition Test Organism Test Conditions Zone Diameter, mm"

lnoculum Incubation 810A ml/ISO ml Temp. C. 5 mg/ml Escherichia coli 5 25 I5 Bacillus species 5 25 22 Proteus vulgaris 5 37 29 Pseudomonas aeruginosa 5 25 7 Serratia marcescens 5 25 7 Staphylococcus aureus 5 25 26 Bacillus sublilis 5 25 33 Sarcina [area 5 2S 26 Staphylococcus aureus 5 37 I9 (Streptomycin-Streptothricinresistant) Streptococcus faecalis I5 37 7 Alcaligenes faecalis 5 37 25 Brucella bronchiseptica IO 37 2| Salmonella gallinarum IO 25 I5 Vibrio percolans I0 27 36 Xanthomonas vesicatoria 5 25 I5 7 mm disc size (no inhibition zone observed) Overnight culture diluted to a reading of 60 mp. on the Lumetron calorimeter.

TABLE VIIv 810A SPECIAL EFFECTS SPECTRUM; In Vitro Study Escherichia coli W-MB-60 Inhibition (with special addition noted) Test Conditions Zone Diameter,

Inoculum Incubation 810A ml/ISO ml Temp. "C. 5 mg/ml Control (no additions) 5 25. l3 0.] M Phosphate Buffer PH 5 5 25 13 0.1 M Phosphate Buffer pH 7 5 25 16 0.1 M Phosphate Buffer pH 9 5 25 l8 Human Blood Plasma 5 I5 Cation Exchange Resin 5 .25 I2 (Dow ET 9I-l%; agar concentration reduced to 1% for resin plate only) 7 mm disc size (no inhibition zone observed) Overnight culture diluted to a reading of mp. on the Lumetron calorimeter.

TAB LE VIII 810A CROSS-RESISTANCE: in Vitro Study Inhibition Escherichia coli Strain Test Conditions Zone Diameter,

lnoculum*** Incubation 810A ml/l50 ml Temp. C. mg/ml Sensitive parent 5 25 I5 Streptomycin-resistant 5 25 13 Streptothricin-resistant 25 I7 OXAMYCIN-resistant I0 25 10 Pleocidin-resistant 10 37 26 Chloramphenicol-resistant 10 25 7 Chlorotetracycline-resistant i0 25 7 Oxytetracyclinc-resistant 1O 25 7 Neomycin-resistant I0 37 Tetracycline-resistant I0 7 Viomycin-resistant 1O 37 17 Polymyxin-resistant I0 25 13 Grisein-resistant 5 25 I5 7 mm disc size (no inhibition zone observed) Tests performed versus a series of strains of E. coli isolated from the same parent culture following exposure to the individual antibiotics Overnight culture diluted to a reading of 60 my. on the Lumetron colorimeter.

Antibiotic 810A; In vivo: The in vivo biological char- TABLE IX acterization indicates that 810A is a broad spectrum antibiotic which protects against infection with two 310A In Vivo Activity f P f S l I] f 25 Route of EDS, ll'l M1crospecies 0 roteus, two 0 a mono a, two strains 0 Test Organism Therapy grams XTWO Doses Escherichia coli, one of Klebstella and three grampositive organisms: Staphylococcus aureus, Streptococ- 33 cus pyogenes and Diplococcus pneumoniae. p.o. 12100 Methods: The method employed in this characteriza- 3O g; 38 tion is as follows. Female white Swiss mice, average Salmonella schatlmuelleri i.p. 419

- s.c. 9000 weight 20-23 grams, were infected mtrapentoneally Escherichia coli LP 3750 with 3- times the number of organisms calculated to be Escherichia coli i.p. I330 lethal for 50% of the infected control animals (3-20 is $228 LD doses). At the time of infection and again six Salmonella pullurum i.p. 625 hours later, therapy was given by the designated route. Dllococcus Immmom W 258 Staphylococcus aureus 1.p. 927

Controls of the virulence of the culture and the toxicity Slrgplgcoccu; pyogenes i p 625 of the antibiotic for uninfected mice were included in the tests. Seven days after infection the test was considered complete and the amount of the antibiotic (I) that would be required to protect of the infected and treated animals was calculated by the method of Knudsen and Curtis; J. Amer. Stat. Assoc. Vol. 42: page 282 (1947).

Results: The results of these tests are listed in Table IV, infra. This data indicates that the antibiotic 810A obtained from culture MA-2837 is a broad spectrum agent, protecting against both gram-positive and gramnegative organisms.

Although effective orally (p.o.) 810A is most effective via the subcutaneous (5.0.) or intraperitoneal (i.p.) route. The antibiotic mixture did not kill uninfected mice when two doses containing 1 mg. each of the product were administered intraperitoneally or when two doses of 18 mg. each were administered subcutaneously or orally.

Antibiotic 842A; In vitro: The in vitro biological characterization was established by the disc-plate agar diffusion method. These tests .were performed by placing 7 mm. discs, wet with the antibiotic solution, on the surface of petri plates poured with 5 ml. of Difco Nutrient Agar and 0.2% Yeast Extract seeded with 5 or 10 ml. of standard cell suspension (OD =0.22 at 660 mg.) per ml. of medium and incubated at 25C. or 37C. for 16 hours as indicated. The method and philosophy of these tests are described in the publication: Cross Resistance Studies and Antibiotic Identification, Applied Microbiology, Vol. 6: pages 392-398 (1958). The following Tables set forth the results of these antibacterial spectrum and cross-resistance tests, and indicate the test organisms used and the conditions employed.

TABLE X 842A ANTIBACTERIAL SPECTRUM; IN VITRO ACTIVITY Test Organism Test Condition INHIBITION ZONE DIAMETER. mm*

Inoculum Incubation Crude 842A (lb) Free Acid Sodium Salt ml/l50 ml Temp. C. 8 mg/ml 166 ag/ml I92 aglml Escherichia coli 5 25 16 20 l8 Bacillus sp. 5 25 7 8 7 Proteus vulgaris 5 37 2| 22 24 Pseudomonas aeruginosa 5 25 7 7 7 Serraria marcescens 5 25 7 7 7 Staphylococcus aureus 5 25 7 7 7 Bacillus subtilis 5 25 l6 l3 l8 Sarcina lulea 5 25 9 l0 9 TABLE X-continued 842A ANTIBACTERIAL SPECTRUM; IN VITRO ACTIVITY Test Organism Test Conditions INHIBITION ZONE DIAMETER. mm

Inoculum Incubation Crude 842A (Ib) Free Acid Sodium Salt ml/I50 ml Temp. C. 8 mg/ml I66 pg/ml I92 pg/ml Staphylococcus aureus 37 7 l I (Streptomycin-Streptothricinresistant) Streptococcus faecalis I5 37 7 7 7 Alcaligenes faecalis 5 37 22 27 7 Brucella bronchiseprica I0 37 28 24 26 Salmonella gallinorum I0 25 21 Vibrio percolans I0 27 37 38 Xamhomonas vcsicatoria 5 25 l2 l9 I7 7 mm disc size (no inhibition zone observed) TABLE XI 842A CROSS RESISTANCE: IN VITRO STUDY Escherichia coli Strain Test Conditions Inoculum Incubation Crude 842A (lb) Free Acid Sodium Salt ml/l ml Temp. C. 8 mg/ml I66 pg/ml I92 pg/ml Sensitive parent 5 25 I6 20 I8 Streptomycin-resistant 5 25 l4 19 I6 Streptothricin-resistant I0 25 I 3 l4 l8 OXMYClN-resistant I0 25 13 I3 I? Pleocidin-resistant I0 37 l5 l8 l7 Chloramphenicol-resistant I0 25 I3 17 I6 Chlortetracycline-resistant I0 25 21 20 23 Oxytetracycline-resistant I0 25 2O 23 24 Neomycin-resistant 1O 37 I8 I 7 I7 Tetracycline-resistant I0 25 I6 20 20 Viomycin-resistant 10 37 15 I6 30 PoIymyxin-resistant I 0 25 23 2l 7 Grisein-resistant 5 25 I8 21 I6 Tests performed versus a series of strains of E. coli isolated from the same parent culture following exposure to the individual antibiotics 7 mm disc size (no inhibition zone observed) TABLE XIa 842A SPECIAL EFFECT SPECTRUM; IN VITRO STUDY Escherichia coli W-MB- (with special addition noted) Test Conditions Inoculum Incubation Crude 842A (lb) Free Acid Sodium Salt ml/l50 ml. Temp. C. 8 mg/ml 166 pg/ml 192 pg/ml Control (no additions) 5 25 I6 20 I8 0.l M Phosphate Buffer 'pH 5 5 25 I9 20 l5 0.] M Phosphate Buffer -pH 7 5 25 22 29 25 0.1 M Phosphate Buffer -pH 9 5 25 21 22 24 Human Blood Plasma 20% 5 25 I7 22 21 *Cation Exchange Resin 5 25 20 21 18 (Dow ET 91 )I% (Agar concentration reduced to 1% for resin plate only) Antlbiotlc 842A; In VIVO TABLE XIb when 842A is given subcutaneously to mice it is generally more active than cephalothin and approximately equal to cephaloridine, ampicillin and chloromycetin in protecting against infection from gram-negative organisms. It is remarkably nontoxic and is rapidly excreted in the urine with approximately 79% of the subcutaneously injected 842A recovered within four hours.

In in vivo studies Antibiotic 842A protects against infection with three species of Proteus, two of Salmonella, one strain of Escherichia coli, two of Klebsiella and also against Paracolobactrum arizonae, Aerobacter aerogenes, Pasteurella multocida and Diplococcus pneumoniae 2400.

The method employed in these studies is the same as described above with regard to the in vivo characterization of 810A. The results of these tests are described below in Table XIb.

842A In Vivo Activity ED by Subcutaneous Test Organism Route X Two Doses THE ANTIBIOTICS 810A Fermentation: The Antibiotic 810A is produced during the aerobic fermentation of suitable aqueous nutrient mediums under controlled conditions via inoculation with the Streptomyces griseus culture MA-2837. Aqueous mediums such as those employed for the production of other antibiotics are also suitable for producing Antibiotic 810A. Such mediums contain sources of carbon and nitrogen assimilable by the microorganism and inorganic salts.

in general, carbohydrates such as sugars, for example, glucose, arabinose, maltose, xylose, mannitol and the like and starches such as grains, for example, oats, rye, corn starch, corn meal and the like can be used either alone or in combination as sources of assimilable carbon in the nutrient medium. The exact quantity of the carbohydrate source or sources utilized in the medium depend in part upon the other ingredients of the medium but, in general, the amount of carbohydrate usually varies between about 1% and 6% by weight of the medium. These carbon sources can be used individually or several such carbon sources may be combined in the medium. In general any proteinaceous material may be used as a nitrogen source in the fermentation process. Suitable nitrogen sources include, for example, yeast hydrolysates, yeast autolysate, soybean meal, hydrolysates of casein, corn steep liquor, distillers solubles or tomato paste and the like. The sources of nitrogen, either alone or in combination, are used in amounts ranging from about 0.2 to 6% by weight of the aqueous medium. Typical of the mediums which are suitable for the preparation of Antibiotic 810 A are those listed below. These mediums and others described in the examples which follow are merely illustrative of the wide variety of media which may be employed and are not intended to be limitative.

Medium 1:

Difco Yeast Extract 10.0 g.

Glucose 10.0 g.

*Phosphate Buffer 2.0 ml.

MgSO. 7H2O 0.05 g.

Distilled Water 1000.0 ml.

Difco Agar 25.0 g.

*Phosphate Buffer: 4O

KHQPQ, 91.0 g. l-la HPO, 95.0 g.

Distilled Water 1000.0 ml.

Medium 11:

Beef Extract 3.0 g. *NZ Amine 10.0 g. Dextrose 10.0 g. NaCl 5.0 g. Distilled H2O 1000.0 ml.

pH adjusted to 7.2 with NaOH *an enzymatic digested casein Medium 111:

Dextrose 10.0 g. Asparagine 1.0 g. K2HPO4 0.1 g. MgSO 7H O 0.5 g. Yeast Extract 0.5 g. *Trace Element Mix N0. 2 10.0 ml. Distilled H2O 1000.0 ml.

pH adjusted to 7.2 with NAOH *Trace Element Mix No. 2:

F650. 71120 1.0 g. MnSO H2O 1.0 g. cucl 211 0 25.0 mg. CaCl 100.0 mg.

(NI-105M010 4H2O 19.0 mg. Znso 711 0 200.0 mg. Distilled H2O 1000.0 ml.

Medium IV:

V8 Juice 100.0 ml. Staleys 4S Soybean Meal 20.0 g. Dextrose 2.0 g. Agar 25.0 g.

Distilled H2O to 1000.0 ml.

-Continued Medium V:

Yeast Autolysate (Ardamine) 10.0 g. Glucose 10.0 g. *Phosphate Buffer 2.0 ml. MGSO. 7H2 O 0.05 g. Distilled H O 1000.0 ml.

pH adjust to 6.5 using NaOl-i *Phosphate Buffer Solution:

KHPO4 91.0 g. Na HPO 95.0 g. Distilled H O 1000.0 ml.

wil

Corn Steep Liquor (wet basis) 40.0 g Dextrose 20.0 g NaCl 2.5 g MgSO, 4 711 0 0.5 g. Polyglycol 2000 0.25% by volume (add to each flask individually) Distilled H O 1000.0 ml.

pH adjust to 7.0 with NaOH Medium V11:

Seed Production L-Asparagine 5.0 g 5.0 g.

L-Histidine 4.0 g 4.0 g.

DL-Phenylalanine 2.0 g.

Monosodium glutamate 1.5 g.

NaCl 5.0 g. 5.0 g.

K HPQ, 2.0 g. 2.0 g.

CaCl 2H 0 0.4 g. 0.4 g.

Mnso. H20 01 g. 0.1 g.

FeSO 71-1 0 0.1 g. 0.1 g.

ZnSO -7H O 0.05 g. 0.05 g.

M so. 711 0 1.0 g. 1.0 g.

Glycerol 20.0 g. 20.0 g.

Sucrose 2.5 g. 2.5 g.

Distilled H20 *1000. ml. 1000.0 m1.

*pH adjusted to 7.0 with NaOH **pH adjusted to 7.1 with Na0H Medium Vlll:

Meat Extract 0.3%

NaCl 0.5%

NZ Amine l Dextrose l The fermentation is carried out at temperatures ranging from about 20C. to 37C.; however, for optimum results it is preferable to conduct the fermentation at temperatures of from about 22C. to 30C. The pH of the nutrient mediums suitable for growing the Streptomyces griseus culture (MA-2837) and producing Anti biotic 810A should be in the range of from about 5.5 to 8.0.

A small scale fermentation of Antibiotic 810A is conveniently carried out by inoculating a suitable nutrient medium with the antibiotic-producing culture and permitting the fermentation to proceed at a constant temperature of from about 2428C. on a shaker over an extended period as, for example, for several days. At the end of the incubation period the mycelium is removed and the supernatant liquid is assayed.

In practice this fermentation is conducted in a sterilized flask via a one, two, three or four stage seed development. The nutrient medium for the seed stage may be any suitable combination of carbon and nitrogen sources as, for example, any one of Mediums l-Vlll described above. The seed flask is shaken in a constant temperature chamber at about 28C. for a period of from 1 to about 3 days and the resulting growth is used to inoculate either a second stage seed or the production medium. Intermediate stage seed flasks, when used, are developed in essentially the same manner, that is, the contents of the flask are used to inoculate the production medium, the inoculated flasks are shaken at a constant temperature for several days and at the end of the incubation period the contents of the flask are centrifuged to remove the mycelium. The supernatant liquid or broth is then concentrated and purified to afford the Antibiotic 810A.

For larger scale work, it is preferable to conduct the fermentation in suitable tanks provided with an agitator and a means of aerating the fermentation medium. According to thismethod, the nutrient medium is made up in the tank and sterilized by heating at temperatures of up to about 120C. Upon cooling, the sterilized medium is inoculated with the producing culture and the fermentation is permitted to proceed for a period of several days as, for example, from 2 to 4 days while agitating and/or aerating the nutrient medium and maintaining the temperature at about 2428C. Through changes in inoculum development and changes in production medium it is possible to achieve a several-fold improvement in production and increase the potency of the antibiotic.

810A Assay Procedure Using Proteus vulgaris: Antibiotic 810A was conveniently assayed by a disc-plate procedure using Proteus vulgaris MB-838 (ATCC 21100 and NRRL B-336l) maintained as a slant culture on nutrient agar (Difco) plus 0.2% yeast extract (Difco) as the test organism. The inoculated slants are incubated at 37C. for 18-24 hours and stored at refrigerator temperatures until used, fresh slants being prepared each week.

The inoculum for the assay plates is prepared each day by inoculating a 250 ml. Erlenmeyer flask containing 50 ml. of nutrient broth (Difco) plus 0.2% yeast extract (Difco) with a scraping from the slant. The flask is incubated at 37C. on a shaking machine for 18-24 hours. The broth culture is then adjusted to 40% transmittance at a wavelength of 660 nm, using a Bausch & Lomb Spectronic 20 by the addition of a 0.2% yeast extract solution to the growth. Uninoculated broth is used as a blank for this determination. The adjusted broth (30 ml.) is used to inoculate 1 liter of medium.

Nutrient agar (Difco) plus 0.2% yeast extract (Difco) is used as the assay medium. This medium is prepared,

sterilized by autoclaving and allowed to cool to 50C. After the medium is inoculated, 10 ml. is added to each of several sterile petri dishes and the medium is allowed to solidify.

Assays were run on these plates by the disc-plate procedure using 0.5 inch filter paper discs. The assay plates were incubated for 20-24 hours at 37C. Assays are expressed as mm. diameter zone of inhibition. They were used to determine relative potencies or, when compared with a purified reference standard, the potency in pg/ml. When such an assay is performed in a quantitative fashion from 2 to 4 ug/ml. of antibiotic can be detected.

810A Assay Procedure Using Vibrio percolans: Assays were also run on 810A by the disc-plate procedure against Vibrio percolans (MB-1272) using 0.5 inch filter paper discs. The assay plates were prepared using Difco nutrient agar plus 2.0 g./liter Difco yeast extract at 10 ml. per plate. An overnight growth of the assay organism, Vibrio percolans (MB-1272) in nutrient broth plus 0.2% yeast extract was diluted in sterile saline solution to a suspension having 40% transmittance at a wave length of 660 mp. This suspension was added at 20 ml./liter of medium prior to pouring the plates.

The assay plates were held at 4C. until used (5 day maximum). Following the application of antibioticsaturated assay discs the plates were incubated at 28C. for a period of from 8 to 24 hours. Zones of inhibition were read as mm. diameter.

Bacterial Inactivation With 810A: An in vitro study was designed to determine the resistance of Antibiotic 810A, to bacterial inactivation as compared with cephalosporin C, cephaloridine and cephalothin. This study showed that Antibiotic 810A is more stable than the latter aganist certain microorganisms.

The degradative bacterium used in this study was an organism known to completely inactivate cephalosporin C, namely, Alcaligenes faecalis (MB-9).

a. Preparation of Bacterial Cells: Alcaligenes faecalis (MB-9) cells were prepared as follows: the contents of an L-tube were mixed with a few ml. of nutrient broth containing 0.2% yeast extract. A loopful of the slurry was spread over the surface of a nutrient agar slant and incubated for 18 hours at 37C. All slants were stored at 5C. and used within 1 week after incubation. A loopful of the surface growth from each slant culture was asceptically transferred to 50 ml. of nutrient broth containing 0.2% yeast extract and shake incubated for 18 hours at 28C. The culture was then centrifuged at 4000 rpm. for 10 minutes. The supernatant was decanted and the residual pellet of cells was washed twice with sterile 0.1 M phosphate buffer, pH 7.5 (6.8 g. of potassium phosphate and 7.1 g. of sodium hydrogen phosphate per liter of distilled water). The washed cells were then resuspended in onetenth original-volume of a 4 mg./ml. solution of antibiotic in 0.1 M phosphate buffer. The test mixture was then incubated without shaking in a water bath set at 37C. for up to 4 hours. The test mixtures were then centrifuged at 2000 rpm. for 10 minutes and this produced a clear supernatant which was decanted into sterile tubes and immediately frozen in dry ice until ready for bioassay, usually within three hours. Controls were incubated in exactly the same manner, except for the absence of cells.

b. Extent of Antibiotic 810A Inactivation: The supernatants were tested for antibacterial activity in the following manner: A inch diameter paper discs were moistened with the supernatants and placed on the surface of nutrient agar-yeast extract (0.2%) plates that had been previously seeded with the appropriate test organism. B. subtilis (MB-964) assay plates were seeded in the following manner: 5 ml. of a suspension of washed spores in 0.9% saline was added to each 150 ml. of nutrient agar-yeast extract (0.2%) of which 5 ml. was then dispensed into 15 X mm. petri plates. All assay plates were stored at 5C. and used within 3 days. Assay plates were incubated overnight at 25C. before measure ment of zones of inhibition around the test discs.

Cell-free controls of each antibiotic were assayed at 1:1, 1:2, 1:4, 1:8, 1:16 and 1:32 dilutions in order to obtain a standard reference curve. Solutions of test antibiotics were assayed at full strength after incubation in the presence of the washed bacterial cells. All samples were run in triplicate.

c. Results: Percents of inactivation were calculated by taking the average of the three zones of inhibition obtained for each test and determining the amount of antibiotic remaining in the test solution as shown by the the standard curve. This value was then subtracted from the starting concentration (4 mg./ml.) and the remainder divided by the starting TABLE XII Percent Inactivation After Incubation With Washed Bacterial Cells (Assayed on B. :ublilis (MB-964) Plates) Antibiotic 3 Hour Incubation With Alcaligenes faecalis 810A Cephalosporin C 99+ Cephalothin 62.5

TABLE XIII Percent Inactivation After Incubation With Washed Bacterial Cells (Assayed on V. percolans (MB-1272) Plates) Antibiotic 3 Hour Incubation With Alcaligenes faecalis 810A 0 Cephalosporin C 99+ Cephalothin 50 The ability of Antibiotic 810A and cephalosporin C to withstand the degradative effect of the culture Aerobacter cloacae (MB-2646) was also determined. This culture is gram-negative and resistant to cephalosporin C. In conducting the assay individual mixtures of the organisms and one of the antibiotic mixtures were sampled after two hours incubation and assayed for residual antibiotic activity. The procedure is the same assay method as described above with Alcaligenes faecalis. The source of the inactivating substance is a 1:160 dilution of the filtrate of an 18 hour 37C. shake culture of Aerobacter cloacae MB-2646 in nutrient broth containing 0.2% yeast extract. Table XIV, infra, indicates the percent inactivation of Antibiotic 810A, cephalothin, cephaloridine and cephalosporin C on Vibrio percolans (MB-l272) via this method:

TABLE XIV Percent Inactivation After Incubation With Cell-Free Extract (Assayed on V. percolans (MB-1272) Plates) Using the same assay procedure as described above, Table XV, infra, indicates the relative resistance of Antibiotic 810A to enzymatic inactivation by Aerobacter cloacae. The starting concentration is 250 ug/ml. Results are expressed in pig/ml.

TABLE XV Antibiotic Activity Remaining (pg/ml.) (Starting Concentration 250 pig/ml.)

Cell-free extract In view of the foregoing, Antibiotic 810A is, apparently, more resistant than cephalosporin C, cephalothin and cephaloridine to inactivation by Aerobacter cloacal.

842A Fermentation: Antibiotic 842A is produced during the aerobic fermentation of suitable aqueous nutrient mediums under controlled conditions via inoculation with the organism Streptomyces lactamdurans. In general, many media which are a source of carbon and nitrogen may be used for the production of 842A. Illustrative of these are the aqueous mediums and carbohydrate and nitrogen sources described above in connection with the fermentation of 810A. The exact amount of the carbohydrate and nitrogen sources will depend upon the other ingredients comprising the fermentation medium but, in general, the amount of carbohydrate is usually about 1% to 6% by weight of the medium and the amount of available nitrogen, either alone or in combination is usually in the amount from about 0.2% to about 6% by weight of the medium. The several media described below are illustrative of those which are suitable for the preparation of Antibiotic 842A. These media are merely typical of the media which may be employed and are not intended to be limitative.

Medium IX:

Amber Yeast No. 300 10.0 g. Distillers Solubles 20.0 g. Dextrose 10.0 g. Distilled Water 1000.0 ml.

pH Medium X Staleys 4S-Soybean Meal 30.0 g. Distillers Solubles 7.5 g. Cerelose 20.0 g. NaCl 2.5 g. CaCO; (after pH to 7.0) 10.0 g. Distilled Water 1000.0 ml. Medium XI:

Amber Yeast No. 300 10.0 g. Distillers Solubles 20.0 g. Distilled Water 1000.0 ml.

The fermentation is carried out at temperatures ranging from about 20C. to 37C. but. for optimum results it is preferable to conduct the fermentation at temperatures of from about 24C. to 32C. The pH of the nutrient mediums suitable for growing the Streptomyces lactamdurans culture (MB-2908) and producing Antibiotic 842A should be in the range of from about 6.0 to about 8.0.

A small scale fermentation of Antibiotic 842A is conveniently carried out by inoculating a suitable nutrient medium with the antibiotic-producing culture and permitting the fermentation to proceed at a constant temperature of about 28C. on a shaker for several days. At the end of the incubation period the mycelium is removed and the supernatant liquid is assayed.

In practice, this fermentation is conducted in a sterilized flask via a one, two, three or four stage seed development. The nutrient medium for the seed stage may be any suitable combination of carbon and nitrogen sources as, for example, and one of Mediums IX-XI described above. The seed flask is shaken in a constant temperature chamber at about 28C. for a period of from 1 to about 3 days and the resulting growth is used to inoculate either a second stage seed or the production medium. Intermediate stage seed flasks, when used, are developed in essentially the same manner, that is, the contents of the flask are used to inoculate the production medium, the inoculated flasks are shaken at a constant temperature for several days and at the end of the incubation period the contents of the flasks are centrifuged to remove the mycelium. The supernatant liquid or broth is then concentrated and purified to afford Antibiotic 842A.

For larger scale work, it is preferable to conduct the fermentation in suitable tanks provided with an agitator and a means of aerating the fermentation medium. According to this method, the nutrient medium is made up in the tank and sterilized by heating at temperatures of up to about 120C. Upon cooling, the sterilized medium is inoculated with the producing culture and the fermentation is permitted to proceed for a period of several days as, for example, from two to four days while agitating and/or aerating the nutrient medium and maintaining the temperature at about 28C. Through changes in inoculum development and changes in production medium it is also possible to achieve a several-fold improvement in production and increase the potency of this antibiotic.

842A Assay Procedure Using Vibrio percolans: Assays were run by the disc-plate procedure using 0.5 inch filter paper discs. The assay plates were prepared using Difco nutrient agar plus 2.0 g/l. Difco yeast extract at 10 ml. per plate. An overnight growth of the assay organism, Vibrio percolans (MB-1272) in nutrient broth and 0.2% yeast extract was diluted in sterile saline solution to a suspension having 40% transmittance at a wave length of 660 nm. This suspension was added at 20 ml./liter of medium prior to pouring the plates.

The assay plates were held at 4C. until used (5 day maximum). Following the application of the antibioticsaturated assay discs the plates were incubated at 28C. for a period of from 8 to 24 hours. Zones of inhibition were read as mm. diameter. They were used to determine relative potencies or, when compared with a puritied reference standard, the potency in ug/ml. When such an assayis performed in a quantitative fashion from 1 to 2 ug./ml. of antibiotic can be detected.

Bacterial Inactivation With 842A: An in vitro study was designed to determine the resistance of Antibiotic 842A to bacterial inactivation as compared with cephalosporin C, cephaloridine and cephalothin. This study showed that Antibiotic 842A is more stable than the latter against certain microorganisms.

The degradative bacteria used in the study were two organisms known to completely inactivate cephalosporin C, namely, Alcaligenes faecalis (MB-9) and Alcaligenes viscosus (MB-12).

a. Preparation of Bacterial Cells: Alcaligenes viscosus (MB-.12) and A. faecalis (MB-9) cells were prepared as follows: the contents of an L-tube were mixed with a few ml. of nutrient broth containing 0.2% yeast extract. A loopful of the slurry was spread over the surface of a nutrient agar slant and incubated for 18 hours at 37C. All slants were stored at 5C. and used within 1 week after incubation. A loopful of the surface growth from each slant culture was asceptically transferred to 50 ml. of nutrient broth containing 0.2% yeast extract and shake incubated for 18 hours at 28C. The culture was then centrifuged at 4000 rpm. for minutes. The supernatant was decanted and the residual pellet of cells was washed twice with sterile 0.1 M phosphate buffer, pH 7.5 (6.8 g. of potassium phosphate, i.e., KH PO and 7.1 g. of sodium hydrogen phosphate per liter of distilled water). The washed cells were then resuspended in one-tenth original volume of a 4 mg./ml. solution of antibiotic in 0.1 M phosphate buffer. The test mixture was then incubated without shaking in a water bath set at 37C. for 4 hours. The test mixtures were then centrifuged at 2000 rpm. for 10 minutes and this produced a clear supernatant which was decanted into sterile tubes and inmediately frozen in dry ice until ready for bioassay, usually within three hours. Controls were incubated in exactly the same manner, except for the absence of cells.

b. Extent of Antibiotic 842A Inactivation: The supernatants were tested for antibacterial activity in the following manner: inch diameter paper discs were moistened with the supernatants and placed on the surface of nutrient agar-yeast extract (0.2%) plates that had been previously seeded with the appropriate test organism. B. subtilis (MB-964) assay plates were seeded in the following manner: 5 ml. of a suspension of washed spores in 0.9% saline was added to each 150 ml. of a 2% nutrient agar-yeast extract (45C.) of which 5 ml. was then dispensed into 15 X mm. petri plates. All assay plates were stored at 5C. and used within 3 days. Assay plates were incubated overnight at 25C. before measurement of zones of inhibition around the test discs.

Cell-free controls of each antibiotic were assayed at 1:1, 1:2, 1:4, 1:8, 1:16 and 1:32 dilutions in order to obtain a standard reference curve. Solutions of test antibiotics were assayed at full strength after incubation in the presence of the washed bacterial cells. All samples were run in triplicate.

c. Results: Percents of inactivation were calculated by taking the average of the three zones of inhibition obtained for each test and determining the amount of antibiotic remaining in the test solution as shown by the standard curve. This value was then subtracted from the starting concentration (4 mg./ml.) and the remainder divided by the starting concentration and multiplied by 100 to obtain the percent of inactivation. The following Table XVI demonstrates the inactivation obtained for cephalosporin C and Antibiotic 842A under the conditions described above.

TABLE XVI Percent Inactivation After Incubation With Washed Bacterial Cells (Assayed on B. sublilis (MB-964) Plates) DEGRADATIVE 4 Hour Incubation ORGANISM Ceph C Antibiotic 842A Alcaligenes faecalis MB'9 99+ 0 A. viscosus MB-l2 99+ 54.5

the same assay method as described above against Alcaligenes faecalis MB-9 and A. viseosus MB-l2. The following table indicates the percent inactivation of cephalosporin C and 842A on B. subtilis (MB-964) via this method:

37 TABLE XVII Culture Ceph C Antibiotic 842A Escherichia cali 236 99 38 Proteus morganii 25] 99 80 Proteus morganii 356 99 69 Proteus mirabilis 241 72 The foregoing data indicates that Antibiotic 842A is, apparently, more resistant than cephalosporin C to inactivation by A. faecalis, A. viscosus, Escherichia coli 236, Proteus morganii 251, Proteus morganii 236 and Proteus mirabilis 241.

The Antibiotic 842A which is obtained via the instant fermentation process is an amphoteric compound with an apparent isoelectric point of about pH 3.5; it is unstable above pH 9.0 but relatively stable at pH 1.5.

Since Antibiotic 810A and Antibiotic 842A and their salts effectively inhibit the growth of various species of Salmonella they can be used as disinfectants in various household and industrial applications. For example, 810A exhibits activity against Salmonella schottmuelleri and S. gallt'narum and 842A exhibits activity against Salmonella schottmuelleri 3010, S. gallinarum and S. typhosa and this property is indicative of their usefulness as sanitizing agents in household and industrial applications.

ISOLATION AND PURIFICATION Antibiotic 810A: Antibiotic 810A can be purified by adsorption on an ion exchange resin as, for example, on synthetic anion exchange resins derived from dextrose or acrylic copolymers or non-ionic cross-linked polymers. The adsorbed antibiotic is eluted from the resin or polymer adsorbate with water or with an aqueous alcoholic solution of a suitable salt such as ammonium chloride or sodium chloride and the like. Illustrative of the ion exchange resins and polymers which may be empolyed are, for example, the DEAE Sephadex A-25, Amberlite lRA-68 and Amberlite XAD-2 mediums described below. If desired the eluate obtained according to the foregoing procedure can be further purified by a second and third adsorption and elution step. Concentrates of all the eluates are then obtained to afford the purified product.

810A Components: Antibiotic 810A can be separated into its components, 7,8-(D-5-amino-5- carboxyvaleramido)-3-(a-methoxy-psulfooxycinnamoyloxymethyl)-7-methoxy-3-cephem- 4-carboxylic acid and 7,8-(D-5-amino-5- carboxyvaleramido)-3-(a-methoxy-phydroxycinnamoyloxymethyl)-7-methoxy-3-cephem-4- carboxylic acid, by chromatographic means. These include:

l. Chromatography on a strongly hydrophylic anion exchange resin such as *DEAE Sephadex A-25, developed with an ammonium bromide-formic acid system. Various concentration of this system may be employed but, in practice, a 0.5 M ammonium bromide 0.1 M formic acid solution is preferred.

2. Chromatography on a weakly basic anion exchange resin such as **Amberlite IRA-68. This is a group separation where material in crude form is fed at a pH of about 3 to 3.5 and eluted first with an acid at a pH of about 2 and then with NaCl/HCI at a pH of about 1.

3. Chromatography on a non-ionic cross-linked polystyrene polymer such as ***Amberlite XAD-2. Elution is effected with a suitable aqueous system but, in general, it is most advantageous to employ a mixture of water and a lower alkyl ketone. Typical of the eluants which may be employed are, for example, 10% methanol in water followed by 50% methanol in water. Alternatively, 20% acetone in water can be substituted for the 50% methanol in water solution. DEAE Sephadex A-25 is a synthetic anion exchange resin derived from the polysaccharide, dextran in its chloride form, i.e., with chloride counter ions; Pharmacia Fine Chemicals, Inc.. 800 Centenial Avenue, Piscataway, New Market, NJ. 08854. A synthetic anion exchange resin; a cross-linked acrylic copolymer containing weakly basic tertiary amino groups; Rohm & Haas Co.. Philadelphia, Pa. 19105. A non-ionic cross-linked polystyrene polymer sorbent; Rhom & Haas Co.. Philadelphia. Pa. 19105.

The individual products obtained via the above methods may be purified by rechromatography. Thus, for example, 7[3-(D-5amino-5-carboxyvaleramido)-3-(amethoxy-p-sulfooxycinnamoyloxymethyl)-7-methoxy- 3-cephem-4-carboxylic acid (1c) may be repurified by subjecting that product to the purification method described in Method 1, supra, followed by desalting on Amberlite XAD-2 absorbent; and 7B-(D-5-amino-5- carboxyvaleramido)-3-(a-methoxy-phydroxycinnamoyloxymethyl)-7-methoxy-3-cephem-4- carboxylic acid may be repurified by rechromatography on a Sephadex A-25 anion exchange resin developed with 0.5 M ammonium bromide and 0.05 M acetic acid.

Antibiotic 842A: The Antibiotic 842A can be purified by adsorption on an ion exchange resin as, for example, on resins composed of quaternary ammonium or sulfonic acid exchange media. The adsorbed antibiotic is eluted from the resin adsorbate with aqueous solutions or with an aqueous alcoholic solution of a suitable salt such as ammonium chloride, sodium chloride and the like. Suitable ion exchange resins which may be employed include, for example, the polystyrene nuclear sulfonic acid resins (45% or 53% water) or polystyrene trimethylbenzylammonium resins (43% water) which are known as Dowex 50 and Dowex 1, respectively. If desired the eluate obtained according to the foregoing procedure can be further purified by a second and third adsorption and elution step. Concentrates of all the eluates are then obtained to afford the purified 842A product.

FORMULATIONS Antibiotic 810A and its individual components and Antibtiotic 842A may be used alone or in combination as the active ingredient in any one of a variety of pharmaceutical preparations. These antibiotics and their corresponding salts may be employed in capsule form or as tablets, powders or liquid solutions or as suspensions or elixirs. They may be administered orally, intravenously or intramuscularly. Suitable carriers which may be used in the composition include, for example, mannitol, sucrose, glucose or sterile liquids such as water, saline glycols and oils of a petroleum, animal, vegetable or synthetic origin as, for example, peanut oil, mineral oil or sesame oil. Also, in addition to a carrier the instant compositions may also include other ingredients such as stabilizers, binders, antioxidants, preservatives, lubricators, suspending agents, viscosity agents, flavoring agents, and the like. In addition, there may also be included in the composition other active ingredients to provide a broader spectrum of antibiotic activity.

The dosage to be administered depends to a large extent upon the condition of the subject being treated and 

1. A METHOD FOR THE PREPARATION OF A MIXTURE OF ANTIBIOTICS HAVING THE FOLLOWING FORMULAS:
 2. THE METHOD OF CLAIM 1 WHEREIN THE STREPTOMYCES IS A STRAIN OF STREPTOMYCES GRISEUS, STREPTOMYCES VIRIDOCHROMOGENES, STREPTOMYCES FIMBRIATUS, STREPTOMYCES HALSTEDII, STREPTOMYCES ROCHEI, STREPTOMYCES CINNAMONENSIS OR STREPTOMYCES CHARTREUSIS.
 3. The method of claim 2 wherein the Streptomyces is Streptomyces griseus.
 4. The method of claim 1 wherein the aqueous nutrient medium contains between about 1% and 6% by weight of carbohydrate and between about 0.2% and 6% by weight of available nitrogen.
 5. The method of claim 1 wherein the fermentation is conducted at a temperature in the range of from about 20*C. to 37*C.
 6. The method of claim 1 wherein the pH of the aqueous nutrient medium is in the range of from about 5.5 to 8.0. 